Stem Loop Mediated Transgene Modulation in Human T Cells

Controlling gene expression is useful for many applications, but current methods often require external user inputs, such as the addition of a drug. We present an alternative approach using cell-autonomous triggers based on RNA stem loop structures in the 3' untranslated regions (UTRs) of mRNA. These stem loops are targeted by the RNA binding proteins Regnase-1 and Roquin-1, allowing us to program stimulation-induced transgene regulation in primary human T cells. By incorporating engineered stem loops into the 3' UTRs of transgenes, we achieved transgene repression through Regnase-1 and Roquin-1 activity, dynamic upregulation upon stimulation, and orthogonal tunability. To demonstrate the utility of this system, we employed it to modulate payloads in CAR-T cells. Our findings highlight the potential of leveraging endogenous regulatory machinery in T cells for transgene regulation and suggest RNA structure as a valuable layer for regulatory modulation.

Authors

Institutions

Publication Details

Journal
ACS Synthetic Biology
Published
2024-12-06
DOI
https://doi.org/10.1021/acssynbio.4c00152
Citations
1
Primary Topic
CAR-T cell therapy research
Type
article
Field-Weighted Citation Impact
0.28

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Stem Loop Mediated Transgene Modulation in Human T Cells

Neil C. Sheppard, Carl H. June, Philipp C. Rommel, David Mai et al.
1 citations
ACS Synthetic Biology
CAR-T cell therapy research
0.28
article

Stem Loop Mediated Transgene Modulation in Human T Cells

Neil C. Sheppard, Carl H. June, Philipp C. Rommel, David Mai, Carly M. Harro, A. Sanyal
article en
1 citations

Abstract

Controlling gene expression is useful for many applications, but current methods often require external user inputs, such as the addition of a drug. We present an alternative approach using cell-autonomous triggers based on RNA stem loop structures in the 3' untranslated regions (UTRs) of mRNA. These stem loops are targeted by the RNA binding proteins Regnase-1 and Roquin-1, allowing us to program stimulation-induced transgene regulation in primary human T cells. By incorporating engineered stem loops into the 3' UTRs of transgenes, we achieved transgene repression through Regnase-1 and Roquin-1 activity, dynamic upregulation upon stimulation, and orthogonal tunability. To demonstrate the utility of this system, we employed it to modulate payloads in CAR-T cells. Our findings highlight the potential of leveraging endogenous regulatory machinery in T cells for transgene regulation and suggest RNA structure as a valuable layer for regulatory modulation.

ACS Synthetic BiologyVol. 13(12)
Parker Institute for Cancer Immunotherapy (US), University of Pennsylvania (US)
Robert Wood Johnson Foundation, University of Pennsylvania, Parker Institute for Cancer Immunotherapy, Emerson Collective, National Institutes of Health, Perelman School of Medicine, University of Pennsylvania
Openalex Percentile: Top 33%
CAR-T cell therapy research
0.28
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.